PVPBSEPVP Ventures LtdMediumNeutral
Announced Fri, 15 May · 17:45 IST

Appointment of Directors

Management Changes View source PDF

PVP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.2%1-day move
₹27.10
prior close
₹26.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.4-1.2-1.1-5.2-3.7-4.0-5.2-4.8-0.6+20.6+7.7+6.1
Up moveDown movePending
AI summary

PVP Ventures Ltd's board meeting on May 15, 2026 approved multiple key appointments and a company name change. Three Non-Executive Independent Directors were appointed: Ms. Saloni Khandelwal (transaction advisory expert from PwC), Dr. Ellen Feehan (medical doctor with MBA from Ireland), and Mr. Srivatsan Kalyanasundaram (ex-McKinsey with international experience). Dr. Neeraja Nagarajan, a healthcare consultant previously with McKinsey, was appointed as both Additional Director and Chief Operating Officer. Mr. Raghu Chaitanya, a Chartered Accountant with 15+ years of experience at companies like ACC and Orient Cement, was appointed as CFO effective June 1, 2026. The company also approved changing its name to 'Evervie Health Limited' and forming an international holding company for healthcare expansion into the Middle East and UK, subject to shareholder and regulatory approvals.

Likely market impact

The company is undergoing a significant leadership overhaul with experienced professionals in healthcare, finance, and advisory roles, signaling a strategic pivot toward the healthcare sector. Shareholders should note all appointments are subject to shareholder approval and the new leadership team brings relevant domain expertise for the healthcare expansion plan.